GHK-Cu and BPC-157 in a 'Glow' blend: what the research actually supports

A recent TikTok video, posted by the creator no.crumbs.wasted, shows a routine dubbed “Time for Glow,” with hashtags referencing GHK-Cu, BPC-157, and a product called “Glow.” The caption implies that combining these peptides produces a synergistic effect for skin health and overall recovery. But what does the research actually say? This article examines the evidence behind GHK-Cu and BPC-157, the two peptides most commonly associated with the “Glow” trend, and clarifies what a 15-second clip cannot convey.

What the clip is claiming

The video suggests that using a “Glow” blend—typically containing GHK-Cu and BPC-157—will improve skin appearance and accelerate healing. The creator’s enthusiastic tone and the hashtag #glow imply a cosmetic and regenerative benefit, but no specific claims are made about dosages, durations, or expected outcomes. The clip is a lifestyle snippet, not a scientific presentation.

What the research neighborhood actually covers

GHK-Cu (copper tripeptide-1) is one of the most studied peptides in dermatology. Research dating back to the 1980s and 1990s shows that GHK-Cu can stimulate collagen production, promote wound healing, and exhibit anti-inflammatory properties. A 2018 review in Wound Repair and Regeneration highlighted GHK-Cu’s role in tissue remodeling and its potential for skin rejuvenation. However, most studies are in vitro or animal models; human clinical trials are limited but generally positive for topical application.

BPC-157, a synthetic pentadecapeptide derived from a protein in gastric juice, has been investigated for its effects on tendon, ligament, and muscle healing. Animal studies, particularly in rats, have shown accelerated healing of Achilles tendons and improved gastrointestinal ulcer recovery. Yet, human data remain scarce, and the peptide is not approved for clinical use by regulatory agencies like the FDA.

Limits, missing context, and what a 15-second clip cannot show

A short video cannot convey the complexity of peptide research. For instance, the “Glow” blend’s efficacy depends on formulation, stability, and route of administration. GHK-Cu is often used topically in cosmetics, while BPC-157 is typically injected—combining them in a single product raises questions about bioavailability and interaction. Moreover, the clip omits potential side effects, contraindications, and the need for medical supervision. Peptides like BPC-157 are not approved for human use, and self-administration carries risks such as infection, allergic reactions, or unknown long-term effects.

How this maps to named research compounds

The catalog includes “Glow” blend, which is likely the product featured in the clip. It also lists GHK-Cu and BPC-157 individually, as well as a BPC-157 + TB-500 blend. The “Glow” blend typically combines GHK-Cu with BPC-157, but the exact ratio and additional ingredients are not specified in the clip. For research purposes, these compounds are studied separately to understand their mechanisms. GHK-Cu is known for copper-dependent signaling, while BPC-157 appears to modulate growth factors and angiogenesis. Combining them may have theoretical benefits, but no peer-reviewed studies have examined this specific blend.

Research-use caveat

All peptides mentioned here are intended for laboratory research only, not for human consumption or cosmetic use. Researchers must adhere to institutional guidelines and ensure proper handling. The information in this article is for educational purposes and does not constitute medical advice.